Survival after treatment of small-cell lung cancer: an endless uphill battle. J Natl Cancer Inst 1997;89(23): 1745-7.Glisson BS,Hong WK.Survival after treatment of small-cell lung cancer:an endless uphill battle. Journal of the National Cancer Institute . 1997...
Treatment protocols for small cell lung cancer (SCLC) are provided below, including the following: First-line therapy Therapy for limited-stage disease Therapy for extensive-stage disease Treatment recommendations for limited-stage SCLC Stages I-III disease: Limited-stage disease is typically treate...
在初步诊断为广泛期SCLC时,18%的患者有脑转移且2年后增至约80%。EORTC(European Organization for Research and Treatment of Cancer)的一项研究,将对化疗有反应的患者随机化分为2组,接受PCI或不接受PCI,发现PCI治疗组1年生存率为27.1%,未接受PCI者为13.3%。[49]在该研究中,PCI不仅减少脑转移的发生率也提高无...
Small cell lung cancer (SCLC) is common in men and women, has a very poor prognosis, and is therefore a major cause of premature mortality. As such, any pr... J,Sarvesvaran,J J,Going,R,Milroy,... - 《Carcinogenesis》 被引量: 9发表: 2019年 Survival After Treatment of Small-Cell ...
What Are Small-Cell Lung Cancer Treatment Options? The most effective treatment for small-cell lung cancer is chemotherapy (using medications to kill cancer cells), either alone or in combination with radiation therapy (using high-dose X-rays or other high-energy rays to kill cancer cells). ...
国际肺癌研究协会(International Association of the Study of Lung Cancer, IASLC)TNM分期系统 2007年IASLC建立了肺癌新的TNM分期系统;这种分期系统包括非小细胞肺癌(NSCLC)和小细胞肺癌。[25] 美国癌症联合委员会(American Joint Commission for Cancer, AJCC)2010年采用了新的TNM分期系统。[26]此外,2011年美国国家综...
(论文)小细胞肺癌的综合治疗进展 the treatment progress of small cell lung cancer.下载积分:1500内容提示:实用肿瘤学杂志摇 圆园员圆 年第 圆远 卷第 员 期总第 员员苑 期 远苑 小细胞肺癌的综合治疗进展徐建宇员 摇 综述摇 徐向英员, 摇 审校 圆 摇 【 摘要】 基于铂类的化疗方案联合胸部放疗已成为...
Treatment of Small Cell Lung Cancer in the Elderly Objective: Since both the incidence of lung cancer and the proportion of the population over age 65 are increasing rapidly in North America, we undertook a... FA Shepherd,FRCPC,MD Esiahas Amdemichael,... - 《Journal of the American Geriatr...
non-small-cell lung cancer;immune checkpoint inhibitors;immunotherapy;anti-PD1/PD-L1;lung resection;safety Graphical Abstract 1. Introduction In the last ten years, the development of immune checkpoint inhibitors (ICIs) has revolutionized the treatment landscape of non-small-cell lung cancers (NSCLC)...
Treatment of relapse of small-cell lung cancer A relapse is when your cancer or the signs of it come back after improving for a while. If the disease doesn’t respond to treatment or gets worse after your initial treatment (called "refractory disease"), your doctor has other ways to ease...